Big Gain For Cyclerion Therapeutics, Inc.
Fri, Jun 14, 2024 at 07:17 PM
Cyclerion Therapeutics, Inc. (CYCN:NASDAQ) soared at $2.72, representing a gain of 32.5%. On Fri, Jun 14, 2024, CYCN:NASDAQ touched a New 2-Week Intraday High of $2.97. From Fri, May 31, 2024, the stock recorded 33.33% Up Days and 20.00% Green Days
About Cyclerion Therapeutics, Inc. (CYCN:NASDAQ)
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop and commercialize breakthrough treatments for serious and orphan diseases.Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators.
Top 10 Gainers:
- La Rosa Holdings Corp. (LRHC:NASDAQ), 75.94%
- Unico American Corporation (UNAM:NASDAQ), 50%
- SRIVARU Holding Limited (SVMH:NASDAQ), 49.18%
- Republic First Bancorp, Inc. (FRBK:NASDAQ), 42.86%
- Nano Nuclear Energy Inc. (NNE:NASDAQ), 32.53%
- Cyclerion Therapeutics, Inc. (CYCN:NASDAQ), 32.47%
- Multi Ways Holdings Limited (MWG:NYSEMKT), 32%
- TRACON Pharmaceuticals, Inc. (TCON:NASDAQ), 29.9%
- Chijet Motor Company Inc. (CJET:NASDAQ), 27.59%
- MOGU Inc. (MOGU:NYSE), 24.49%